Filing Flows

Filing Flows › Comparisons › HBIO vs MASS

Harvard Bioscience vs 908 Devices: HBIO and MASS compared

Harvard Bioscience is the larger company: $22.7M of revenue in its latest quarter (Q2 2026) against $16.1M for 908 Devices (Q2 2026). 908 Devices is growing faster (+23% against +11% a year earlier). Harvard Bioscience is more profitable, with an operating margin of -4.3% against -79.7%.

Harvard Bioscience vs 908 Devices, latest quarterHarvard Bioscience vs 908 Devices, latest quarterHarvard Bioscience (HBIO)908 Devices (MASS)Revenue$22.7M$16.1MRevenue growth, Y/Y+11%+23%Operating margin-4.3%-79.7%Net margin-12.8%-74.0%

Where the money goes: HBIO and MASS

Harvard Bioscience (HBIO) · Q2 2026

Harvard Bioscience, Q2 2026: revenue $22.7M (+11% year over year), operating margin -4.3%, net loss $2.9M, operating cash flow $325K. The chart follows the revenue to costs, profit and cash.

908 Devices (MASS) · Q2 2026

908 Devices, Q2 2026: revenue $16.1M (+23% year over year), operating margin -79.7%, net loss $11.9M, operating cash flow $3.2M. The chart follows the revenue to costs, profit and cash.

Harvard Bioscience revenue by segment, Q2 2026Harvard Bioscience revenue by segment, Q2 2026Instruments, Equipment, Software,…$20.3MService, Maintenance, and Warrant…$2.4M
908 Devices revenue by segment, Q2 2026908 Devices revenue by segment, Q2 2026Device sales revenue$11.0MRecurring revenue$4.9MContract revenue$104K
Harvard Bioscience (HBIO)908 Devices (MASS)
Latest quarterQ2 2026Q2 2026
Revenue$22.7M$16.1M
Revenue growth, Y/Y+11%+23%
Operating margin-4.3%-79.7%
Net earnings−$2.9M−$11.9M
Net margin-12.8%-74.0%
Operating cash flow$325K$3.2M
Free cash flow—$3.0M

Where the revenue comes from

Harvard Bioscience

908 Devices

Questions

Which is bigger, Harvard Bioscience or 908 Devices?

Harvard Bioscience is the larger company: $22.7M of revenue in its latest quarter (Q2 2026) against $16.1M for 908 Devices (Q2 2026).

Is Harvard Bioscience or 908 Devices growing faster?

908 Devices is growing faster (+23% against +11% a year earlier).

Which is more profitable, Harvard Bioscience or 908 Devices?

Harvard Bioscience is more profitable, with an operating margin of -4.3% against -79.7%.

More: Harvard Bioscience earnings · how Harvard Bioscience makes money · 908 Devices earnings · how 908 Devices makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 11, 2026; 10-Q filed Aug 11, 2026). Fiscal quarters can end on different dates. Not investment advice.